Scarica l'app Stockscreener
41.66
0.14%
-0.06
Dopo l'orario di chiusura:
41.00
-0.66
-1.58%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GH Giù?
Forum
Previsione
Precedente Chiudi:
$41.72
Aprire:
$42.47
Volume 24 ore:
2.23M
Relative Volume:
0.96
Capitalizzazione di mercato:
$5.46B
Reddito:
$692.26M
Utile/perdita netta:
$-512.41M
Rapporto P/E:
-9.8255
EPS:
-4.24
Flusso di cassa netto:
$-274.36M
1 W Prestazione:
-5.43%
1M Prestazione:
-4.69%
6M Prestazione:
+40.13%
1 anno Prestazione:
+86.23%
Intervallo 1D:
$41.05
$43.46
Intervallo di 1 settimana:
$38.86
$44.09
Portata 52W:
$20.14
$52.92
Guardant Health Inc Stock (GH) Company Profile
Nome
Guardant Health Inc
Settore
Industria
Telefono
855-698-8887
Indirizzo
3100 HANOVER STREET, PALO ALTO
Confronta GH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
41.66 | 5.46B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
432.59 | 159.40B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
200.83 | 141.27B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
509.53 | 38.21B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.55 | 30.90B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
156.13 | 26.35B | 15.50B | 1.33B | 2.16B | 7.34 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-28 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-24 | Ripresa | Craig Hallum | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Neutral |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-11-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-27 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-26 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-03-09 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-11-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | Iniziato | Craig Hallum | Buy |
| 2022-10-06 | Iniziato | Stephens | Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-06-03 | Iniziato | Piper Sandler | Overweight |
| 2022-04-28 | Ripresa | BTIG Research | Buy |
| 2022-02-24 | Reiterato | Canaccord Genuity | Buy |
| 2022-02-24 | Reiterato | Citigroup | Buy |
| 2022-02-24 | Reiterato | Cowen | Outperform |
| 2022-02-24 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-24 | Reiterato | SVB Leerink | Outperform |
| 2022-02-24 | Reiterato | Stifel | Buy |
| 2022-02-24 | Reiterato | Wells Fargo | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-11 | Iniziato | Stifel | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Overweight |
| 2020-06-12 | Iniziato | BTIG Research | Buy |
| 2020-02-21 | Iniziato | Guggenheim | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-08-07 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-16 | Iniziato | Canaccord Genuity | Buy |
| 2019-04-10 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | Reiterato | BofA/Merrill | Neutral |
| 2018-10-29 | Iniziato | BofA/Merrill | Neutral |
| 2018-10-29 | Iniziato | JP Morgan | Overweight |
| 2018-10-29 | Iniziato | William Blair | Outperform |
Mostra tutto
Guardant Health Inc Borsa (GH) Ultime notizie
How to Take Advantage of moves in (GH) - news.stocktradersdaily.com
Guardant Health to Participate in Upcoming Investor ConferencesMay 8, 2025 - BioSpace
TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List of the 100 Most Influential People in Global Health This Year - 01net
TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List of the 100 Most Influential People in Global Health This Year | GH Stock News - GuruFocus
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - BioSpace
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | GH Stock News - GuruFocus
Guardant Health (GH) Price Target Raised by Piper Sandler to $60 | GH Stock News - GuruFocus
Piper Sandler Boosts Guardant Health (GH) Price Target to $60 | - GuruFocus
Piper Sandler Boosts Guardant Health (GH) Price Target to $60 | GH Stock News - GuruFocus
Guardant Health (GH): Scotiabank Raises Price Target to $57.00 | - GuruFocus
Genomic Cancer Testing Market Grows with Advances in Precision - openPR.com
Scotiabank Increases Guardant Health (GH) Price Target After Strong Q1 Performance | GH Stock News - GuruFocus
Guardant Health, Inc. (NASDAQ:GH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$59.17 - Yahoo Finance
Decoding Guardant Health Inc (GH): A Strategic SWOT Insight - GuruFocus
Guardant Health’s (NASDAQ:GH) Q4: Beats On Revenue - Barchart.com
Guardant Health, Inc. (NASDAQ:GH) Q1 2025 Earnings Call Transcript - Insider Monkey
Morgan Stanley Raises Price Target on Guardant Health to $60 From $52, Keeps Overweight Rating - marketscreener.com
Guardant Health (GH) Price Target Boosted by BTIG to $65 Amid St - GuruFocus
Guardant Health stock soars to 52-week high of $52.49 By Investing.com - Investing.com India
Guardant Health Reports Strong Q1 Revenue Growth - TipRanks
Guardant Health (GH) Sees Target Price Raised by TD Securities | - GuruFocus
Stifel Raises Price Target for Guardant Health (GH) to $60 | GH Stock News - GuruFocus
Canaccord raises Guardant Health target to $65, maintains Buy By Investing.com - Investing.com Canada
Guardant Health (GH) Sees Price Target Raised by Canaccord Genui - GuruFocus
Guardant Health: Tailwinds Are Beginning To Impact The Financials (NASDAQ:GH) - Seeking Alpha
Guardant Health (GH) Sees Price Target Raised by Canaccord Genuity | GH Stock News - GuruFocus
Guardant Health (GH) Price Target Increased Amid Positive Moment - GuruFocus
Guardant Health (GH) Receives Price Target Boost from UBS | GH S - GuruFocus
Guardant Health (GH) Stock Target Price Raised by Barclays Analy - GuruFocus
Guardant Health (GH) Stock Target Price Raised by Barclays Analyst | GH Stock News - GuruFocus
Guardant Health (GH) Receives Price Target Increase from UBS | G - GuruFocus
Guardant Health stock soars to 52-week high of $52.49 - Investing.com
UBS Adjusts Guardant Health Price Target to $70 From $65, Maintains Buy Rating - marketscreener.com
Canaccord raises Guardant Health target to $65, maintains Buy - Investing.com
Guardant Health (GH) Price Target Boosted by BTIG to $65 Amid Strong Growth | GH Stock News - GuruFocus
Canaccord Increases Guardant Health (GH) Price Target to $65 | G - GuruFocus
Guardant Health Inc (GH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Barclays Lifts Guardant Health (GH) Price Target Amid Business G - GuruFocus
Earnings call transcript: Guardant Health Q1 2025 beats EPS forecast, revenue rises - Investing.com Nigeria
Guardant Health Q1 Adjusted Loss Widen, Revenue Rises; 2025 Revenue Guidance Raised - marketscreener.com
Guardant Health Inc (GH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Guardant Health Surpasses Q1 2025 Revenue ExpectationsNews and Statistics - IndexBox
Guardant Health: Q1 Earnings Snapshot - New Haven Register
Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - BioSpace
Guardant Health up 4% on Q1 beats, 2025 guidance revenue raise - MSN
Guardant Health (GH) Reports Strong Q1 2025 Revenue Growth - GuruFocus
Guardant Health, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:GH) - Seeking Alpha
Guardant Health Inc Azioni (GH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.60%
2.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):